Categories: Life Science | Format :
MARKET DEFINITION
Patients who receive replacement enzymes as part of an ERT regimen are treated for chronic conditions brought on by enzyme deficiency or dysfunction. ERT is used to treat lysosome storage diseases (LSDs), which are unordinary, inherited, chronic conditions brought on by a lack of or dysfunction in lysosomal enzymes. The most well-liked type of ERT is IV infusions, which deliver the replacement enzyme directly into the bloodstream using a carefully controlled fluid drip. Before being administered to the patient, the replacement enzymes for ERT are made in human, animal, and plant cells, processed, and genetically altered. The body can perform the tasks that the deficiency had prevented by ingesting these replacement enzymes. Although ERT isn't always the best option, it can be effective depending on the patient and the condition being treated.
MARKET DYNAMICS
One of the major drivers of the market's growth is the increase in chronic and fatal lysosomal storage diseases like Fabry disease, Gaucher disease, and Pompe disease, among others. The market is expanding as a result of increased technological intervention in therapies and treatments. Furthermore, the high cost of treatment, the emergence of enzyme resistance, and uneven bio-distribution restrict market growth. New therapeutic advancements and an increase in product pipeline analysis also create opportunities for market expansion. Additionally, the opportunity for expansion presented by the rise in demand for better healthcare services is causing the healthcare sector in emerging economies to grow at a very significant rate.
REPORT SCOPE
The report titled “Global Enzyme Replacement Therapy Market – Size, Share, Growth, Opportunities, and Competitive Analysis, 2022 – 2028” offers strategic visions into the global Enzyme Replacement Therapy market along with the market size (Value in “US$ Mn”) for the historical period 2017 to 2021 and estimates for the forecast period 2022 to 2028. The RI report is an in-depth study of the global Enzyme Replacement Therapy market with a strong focus on key market trends, vital player strategies, and market forecasts. The study also covers key market dynamics, including drivers, restraints, opportunities, challenges, and existing and upcoming pathways that help CXOs make critical business decisions effectively. The global Enzyme Replacement Therapy Market is predicted to grow at a significant CAGR over the forecast period from 2022 to 2028.
GEOGRAPHICAL OVERVIEW
The research report includes a detailed overview of the industry comprising quantitative and qualitative information. It gives a broad overview of the worldwide market forecasts for major segments. It also includes market size and forecast projections for five key regions: North America, Europe, Asia-Pacific (APAC), South America, and the Middle East & Africa (MEA), for the years 2017 to 2028. The market is further divided by categories and countries within each province. The research scrutinizes and forecasts over 20 nations worldwide, as well as the present trend and possibilities in these regions.
MARKET SEGMENTATION
The Global Enzyme Replacement Therapy Market is segmented based on Enzyme Type, Route of Administration, Indication, End User, and Region. Based on Enzyme Type, the market has been segmented into Agalsidase Alfa, and Agalsidase Beta, whereas based on Route of Administration, the market comprises Parenteral, and Oral. Based on Indication, the market has been segmented into Steatorrhoea, Exocrine Pancreatic Insufficiency (EPI), Lysosomal storage diseases (LSDs), Mucopolysaccharidosis, and Others, whereas, the End User segmentation includes Hospital, Specialty Clinics, and Others.
COMPETITION LANDSCAPE
The RI research report discusses noteworthy developments in the industry as well as organic and inorganic growth strategies being adopted by the Enzyme Replacement Therapy market players. The report covers industry activities, including new product launches, mergers & acquisitions, business partnerships, and various expansion initiatives being undertaken by the active players in the market. These developments pave the path for various market participants to strengthen their positioning as well as expand their consumer base. The positive market outlook for the global Enzyme Replacement Therapy market is anticipated to present lucrative growth opportunities to the market players. The report also offers detailed profiles of major players in the global Enzyme Replacement Therapy market, emphasizing the strategic initiatives, financial information, SWOT analysis, and key development in the Enzyme Replacement Therapy industry in the past three years.
Key players in the Global Enzyme Replacement Therapy Market have adopted various organic as well as inorganic growth strategies to strengthen their market positioning. Prominent players in the market include:
· Takeda Pharmaceutical Company Limited
· Sanofi S.A.
· AbbVie Inc.
· BioMarin Pharmaceutical Inc.
· Amicus Therapeutics
· Alexion Pharmaceuticals, Inc. (AstraZeneca)
· Janssen Pharmaceuticals (Johnson & Johnson Services, Inc.)
· Recordati S.p.A
· Pfizer Inc
· CHIESI Farmaceutici S.p.A
· JCR Pharma
COVID-19 IMPACT ANALYSIS ON GLOBAL ENZYME REPLACEMENT THERAPY MARKET
The COVID-19 pandemic is still a very personal, individual experience that is also a once-in-a-lifetime worldwide phenomenon with far-reaching consequences. The epidemic has wreaked havoc on people's lives in all nations and communities and also had a negative impact on global economic development in 2020, unlike anything seen in almost a century. The pandemic severely impacted key economies such as India, Brazil, the U.S., France, Russia, the UK, Italy, Turkey, and Argentina. According to estimates, the virus slowed global economic growth by -3.4 percent to -7.6 percent in 2020, with a rebound of 4.2 percent to 5.6 percent expected in 2021. In 2020, global commerce was expected to decline by 5.3 percent, but it is expected to rise by 8.0 percent in 2021.
In contrast to the global economic downturn in the first half of 2020, the economy began to showcase symptoms of a two-track recovery post the second quarter of 2020, with a fledgling rebound in developed nations, however, slower growth in emerging economies. The outbreak of the Covid-19 pandemic has not only resulted in halted production activity but has also disrupted the global supply chain. The research goes on to evaluate the current and future implications of the COVID-19 pandemic both on the target as well as broader market, thereby, providing accurate and trustworthy forecasts.
Report Attribute/Metric |
Details |
Market Size |
In USD Million |
CAGR |
In % (2022-2028) |
Base Year |
2021 |
Forecast Period |
2022 – 2028 |
Historical Data |
2017 to 2021 |
Forecast Unit |
Value (US$ Mn) |
Report Coverage |
Revenue Forecast, Competitive Landscape, Growth Factors and Trends |
Geographies Covered |
North America, Europe, Asia-Pacific, South America, and Middle East & Africa |
Key Players Analyzed |
Takeda Pharmaceutical Company Limited, Sanofi S.A., AbbVie Inc., BioMarin Pharmaceutical Inc., Amicus Therapeutics, Alexion Pharmaceuticals, Inc., AstraZeneca), Janssen Pharmaceuticals (Johnson & Johnson Services, Inc.), Recordati S.p.A, Pfizer Inc, CHIESI Farmaceutici S.p.A, JCR Pharma, and Others |
Customization & Pricing |
Available on Request (10% Customization is Free) |
RESEARCH PROGRAM DESIGN
KEY QUESTIONS ANSWERED
1. What is the current size of the global Enzyme Replacement Therapy market?
2. What will be the growth rate of the market over the forecast period?
3. Who are the key manufacturers/vendors in the Enzyme Replacement Therapy market space?
4. What are the major market opportunities and market risks faced by the market?
5. What is the impact of COVID-19 on the market?
6. What are the revenue, sales, and price analysis of the top manufacturers in this market?
7. What are the key outcomes of Porter's five forces model?
8. Who are the distributors, traders, and vendors in the industry?
REASONS FOR BUYING THIS REPORT:
· The report offers comprehensive data on the Enzyme Replacement Therapy market elaborating on the current state and future growth prospects both globally and regionally
· It offers a six-year market forecast trend evaluating the impact of drivers and restraints and supporting factors for growth
· The report offers deep-dive insights into each market segment and critical factors responsible for its growth
· The report presents precise picture of the dynamic competitive landscape which helps our client advance their market position
· The comprehensive analysis of the market along with the inclusion of analyst recommendations ensures that our clients make informed business decisions
· Cross-segment country-level analysis included in the report which provides granular analysis of more than 20+ countries covered in the report scope
· The study includes detailed profiles of major manufacturers to help our readers gain holistic overview of the market competitors and consequently align their business strategies
Chapter 1. Executive Summary
1.1. Market Outlook
1.2. Market Segment Outlook
1.3. Geography Outlook
1.4. Absolute $ Opportunity
Chapter 2. Research Methodology
2.1. Research Approach
2.2. Scope, Definition, and Assumptions
2.3. Data Sources
2.3.1. Secondary Sources
2.3.1.1. Preliminary Data Mining
2.3.2. Primary Sources
2.3.2.1. Statistical Indication
2.3.2.2. Data Triangulation
2.3.2.3. Research Objective
Chapter 3. Market Outlook
3.1. Introduction
3.2. Key Trends
3.2.1. Enzyme Type Trends
3.2.2. Route of Administration Trends
3.2.3. Indication Trends
3.2.4. End User Trends
3.3. Market Dynamics
3.3.1. Market Drivers
3.3.1.1. Impact Analysis of Market Drivers
3.3.2. Market Restraints
3.3.2.1. Impact Analysis of Market Restraints
3.3.3. Market Opportunities
3.3.3.1. Impact Analysis of Market Opportunities
3.3.4. Market Challenges
3.3.4.1. Impact Analysis of Market Challenges
3.4. Porter’s Five Forces’ Analysis
3.4.1. Bargaining Power of Suppliers
3.4.2. Bargaining Power of Buyers
3.4.3. Threat of New Entrant
3.4.4. Threat of Substitutes
3.4.5. Competitive Rivalry
3.5. Value Chain Analysis: Global Enzyme Replacement Therapy Market
3.6. COVID-19 Impact Assessment in Enzyme Replacement Therapy Market
3.6.1. Impact Assessment on Global Enzyme Replacement Therapy Market
3.6.2. Market Trends and Opportunities in the Covid-19 Landscape
Chapter 4. Global Enzyme Replacement Therapy Market Overview, By Enzyme Type, 2017 - 2028 (USD Million)
4.1. Global Enzyme Replacement Therapy Market Share, By Enzyme Type, 2017 - 2028 (USD Million)
4.1.1. Agalsidase Alfa
4.1.2. Agalsidase Beta
Chapter 5. Global Enzyme Replacement Therapy Market Overview, By Route of Administration, 2017 - 2028 (USD Million)
5.1. Global Enzyme Replacement Therapy Market Share, By Route of Administration, 2017 - 2028 (USD Million)
5.1.1. Parenteral
5.1.2. Oral
Chapter 6. Global Enzyme Replacement Therapy Market Overview, By Indication, 2017 - 2028 (USD Million)
6.1. Global Enzyme Replacement Therapy Market Share, By Indication, 2017 - 2028 (USD Million)
6.1.1. Steatorrhoea
6.1.2. Exocrine Pancreatic Insufficiency (EPI)
6.1.3. Lysosomal storage diseases (LSDs)
6.1.4. Mucopolysaccharidosis
6.1.5. Others
Chapter 7. Global Enzyme Replacement Therapy Market Overview, By End User, 2017 - 2028 (USD Million)
7.1. Global Enzyme Replacement Therapy Market Share, By End User, 2017 - 2028 (USD Million)
7.1.1. Hospital
7.1.2. Specialty Clinics
7.1.3. Others
Chapter 8. Global Enzyme Replacement Therapy Market Overview, By Geography, 2017 - 2028 (USD Million)
8.1. Global Enzyme Replacement Therapy Market Share, By Geography, 2017 - 2028 (USD Million)
8.1.1. Market Route of Administration and Projections, by Countries, 2017 - 2028 (USD Million)
8.1.2. Market Share and CAGR Comparison, by Countries, 2021 (%)
Chapter 9. North America Enzyme Replacement Therapy Market Overview, By Countries, 2017 - 2028 (USD Million)
9.1. North America Enzyme Replacement Therapy Market Overview, 2017 - 2028 (USD Million)
9.1.1. Market Route of Administration and projections, 2017 - 2028 (USD Million)
9.1.2. North America Enzyme Replacement Therapy Market Overview, By Enzyme Type, 2017 - 2028 (USD Million)
9.1.3. North America Enzyme Replacement Therapy Market Overview, By Route of Administration, 2017 - 2028 (USD Million)
9.1.4. North America Enzyme Replacement Therapy Market Overview, By Indication, 2017 - 2028 (USD Million)
9.1.5. North America Enzyme Replacement Therapy Market Overview, By End User, 2017 - 2028 (USD Million)
9.1.6. North America Enzyme Replacement Therapy Market Overview, By Application, 2017 - 2028
9.2. North America Enzyme Replacement Therapy Market Overview, By Countries, 2017 - 2028 (USD Million)
9.2.1. U.S. Enzyme Replacement Therapy Market Overview, 2017 - 2028 (USD Million)
9.2.1.1. U.S. Enzyme Replacement Therapy Market Overview, By Enzyme Type, 2017 - 2028 (USD Million)
9.2.1.2. U.S. Enzyme Replacement Therapy Market Overview, By Route of Administration, 2017 - 2028 (USD Million)
9.2.1.3. U.S. Enzyme Replacement Therapy Market Overview, By Indication, 2017 - 2028 (USD Million)
9.2.1.4. U.S. Enzyme Replacement Therapy Market Overview, By End User, 2017 - 2028 (USD Million)
9.2.2. Canada Enzyme Replacement Therapy Market Overview, 2017 - 2028 (USD Million)
9.2.2.1. Canada Enzyme Replacement Therapy Market Overview, By Enzyme Type, 2017 - 2028 (USD Million)
9.2.2.2. Canada Enzyme Replacement Therapy Market Overview, By Route of Administration, 2017 - 2028 (USD Million)
9.2.2.3. Canada Enzyme Replacement Therapy Market Overview, By Indication, 2017 - 2028 (USD Million)
9.2.2.4. Canada Enzyme Replacement Therapy Market Overview, By End User, 2017 - 2028 (USD Million)
9.2.3. Mexico Enzyme Replacement Therapy Market Overview, 2017 - 2028 (USD Million)
9.2.3.1. Mexico Enzyme Replacement Therapy Market Overview, By Enzyme Type, 2017 - 2028 (USD Million)
9.2.3.2. Mexico Enzyme Replacement Therapy Market Overview, By Route of Administration, 2017 - 2028 (USD Million)
9.2.3.3. Mexico Enzyme Replacement Therapy Market Overview, By Indication, 2017 - 2028 (USD Million)
9.2.3.4. Mexico Enzyme Replacement Therapy Market Overview, By End User, 2017 - 2028 (USD Million)
Chapter 10. Europe Enzyme Replacement Therapy Market Overview, By Countries, 2017 - 2028 (USD Million)
10.1. Europe Enzyme Replacement Therapy Market Overview, 2017 - 2028 (USD Million)
10.1.1. Market Route of Administration and projections, 2017 - 2028 (USD Million)
10.1.2. Europe Enzyme Replacement Therapy Market Overview, By Enzyme Type, 2017 - 2028 (USD Million)
10.1.3. Europe Enzyme Replacement Therapy Market Overview, By Route of Administration, 2017 - 2028 (USD Million)
10.1.4. Europe Enzyme Replacement Therapy Market Overview, By Indication, 2017 - 2028 (USD Million)
10.1.5. Europe Enzyme Replacement Therapy Market Overview, By End User, 2017 - 2028 (USD Million)
10.2. Europe Enzyme Replacement Therapy Market Overview, By Countries, 2017 - 2028 (USD Million)
10.2.1. Germany Enzyme Replacement Therapy Market Overview, 2017 - 2028 (USD Million)
10.2.1.1. Germany Enzyme Replacement Therapy Market Overview, By Enzyme Type, 2017 - 2028 (USD Million)
10.2.1.2. Germany Enzyme Replacement Therapy Market Overview, By Route of Administration, 2017 - 2028 (USD Million)
10.2.1.3. Germany Enzyme Replacement Therapy Market Overview, By Indication, 2017 - 2028 (USD Million)
10.2.1.4. Germany Enzyme Replacement Therapy Market Overview, By End User, 2017 - 2028 (USD Million)
10.2.2. France Enzyme Replacement Therapy Market Overview, 2017 - 2028 (USD Million)
10.2.2.1. France Enzyme Replacement Therapy Market Overview, By Enzyme Type, 2017 - 2028 (USD Million)
10.2.2.2. France Enzyme Replacement Therapy Market Overview, By Route of Administration, 2017 - 2028 (USD Million)
10.2.2.3. France Enzyme Replacement Therapy Market Overview, By Indication, 2017 - 2028 (USD Million)
10.2.2.4. France Enzyme Replacement Therapy Market Overview, By End User, 2017 - 2028 (USD Million)
10.2.3. UK Enzyme Replacement Therapy Market Overview, 2017 - 2028 (USD Million)
10.2.3.1. UK Enzyme Replacement Therapy Market Overview, By Enzyme Type, 2017 - 2028 (USD Million)
10.2.3.2. UK Enzyme Replacement Therapy Market Overview, By Route of Administration, 2017 - 2028 (USD Million)
10.2.3.3. UK Enzyme Replacement Therapy Market Overview, By Indication, 2017 - 2028 (USD Million)
10.2.3.4. UK Enzyme Replacement Therapy Market Overview, By End User, 2017 - 2028 (USD Million)
10.2.4. Italy Enzyme Replacement Therapy Market Overview, 2017 - 2028 (USD Million)
10.2.4.1. Italy Enzyme Replacement Therapy Market Overview, By Enzyme Type, 2017 - 2028 (USD Million)
10.2.4.2. Italy Enzyme Replacement Therapy Market Overview, By Route of Administration, 2017 - 2028 (USD Million)
10.2.4.3. Italy Enzyme Replacement Therapy Market Overview, By Indication, 2017 - 2028 (USD Million)
10.2.4.4. Italy Enzyme Replacement Therapy Market Overview, By End User, 2017 - 2028 (USD Million)
10.2.5. Spain Enzyme Replacement Therapy Market Overview, 2017 - 2028 (USD Million)
10.2.5.1. Spain Enzyme Replacement Therapy Market Overview, By Enzyme Type, 2017 - 2028 (USD Million)
10.2.5.2. Spain Enzyme Replacement Therapy Market Overview, By Route of Administration, 2017 - 2028 (USD Million)
10.2.5.3. Spain Enzyme Replacement Therapy Market Overview, By Indication, 2017 - 2028 (USD Million)
10.2.5.4. Spain Enzyme Replacement Therapy Market Overview, By End User, 2017 - 2028 (USD Million)
10.2.6. NORDIC Enzyme Replacement Therapy Market Overview, 2017 - 2028 (USD Million)
10.2.6.1. NORDIC Enzyme Replacement Therapy Market Overview, By Enzyme Type, 2017 - 2028 (USD Million)
10.2.6.2. NORDIC Enzyme Replacement Therapy Market Overview, By Route of Administration, 2017 - 2028 (USD Million)
10.2.6.3. NORDIC Enzyme Replacement Therapy Market Overview, By Indication, 2017 - 2028 (USD Million)
10.2.6.4. NORDIC Enzyme Replacement Therapy Market Overview, By End User, 2017 - 2028 (USD Million)
10.2.7. Russia and CIS Enzyme Replacement Therapy Market Overview, 2017 - 2028 (USD Million)
10.2.7.1. Russia and CIS Enzyme Replacement Therapy Market Overview, By Enzyme Type, 2017 - 2028 (USD Million)
10.2.7.2. Russia and CIS Enzyme Replacement Therapy Market Overview, By Route of Administration, 2017 - 2028 (USD Million)
10.2.7.3. Russia and CIS Enzyme Replacement Therapy Market Overview, By Indication, 2017 - 2028 (USD Million)
10.2.7.4. Russia and CIS Enzyme Replacement Therapy Market Overview, By End User, 2017 - 2028 (USD Million)
10.2.8. Rest of Europe Enzyme Replacement Therapy Market Overview, 2017 - 2028 (USD Million)
10.2.8.1. Rest of Europe Enzyme Replacement Therapy Market Overview, By Enzyme Type, 2017 - 2028 (USD Million)
10.2.8.2. Rest of Europe Enzyme Replacement Therapy Market Overview, By Route of Administration, 2017 - 2028 (USD Million)
10.2.8.3. Rest of Europe Enzyme Replacement Therapy Market Overview, By Indication, 2017 - 2028 (USD Million)
10.2.8.4. Rest of Europe Enzyme Replacement Therapy Market Overview, By End User, 2017 - 2028 (USD Million)
Chapter 11. Asia Pacific Enzyme Replacement Therapy Market Overview, By Countries, 2017 - 2028 (USD Million)
11.1. Asia Pacific Enzyme Replacement Therapy Market Overview, 2017 - 2028 (USD Million)
11.1.1. Market Route of Administration and projections, 2017 - 2028 (USD Million)
11.1.2. Asia Pacific Enzyme Replacement Therapy Market Overview, By Enzyme Type, 2017 - 2028 (USD Million)
11.1.3. Asia Pacific Enzyme Replacement Therapy Market Overview, By Route of Administration, 2017 - 2028 (USD Million)
11.1.4. Asia Pacific Enzyme Replacement Therapy Market Overview, By Indication, 2017 - 2028 (USD Million)
11.1.5. Asia Pacific Enzyme Replacement Therapy Market Overview, By End User, 2017 - 2028 (USD Million)
11.2. Asia Pacific Enzyme Replacement Therapy Market Overview, By Countries, 2017 - 2028 (USD Million)
11.2.1. India Enzyme Replacement Therapy Market Overview, 2017 - 2028 (USD Million)
11.2.1.1. India Enzyme Replacement Therapy Market Overview, By Enzyme Type, 2017 - 2028 (USD Million)
11.2.1.2. India Enzyme Replacement Therapy Market Overview, By Route of Administration, 2017 - 2028 (USD Million)
11.2.1.3. India Enzyme Replacement Therapy Market Overview, By Indication, 2017 - 2028 (USD Million)
11.2.1.4. India Enzyme Replacement Therapy Market Overview, By End User, 2017 - 2028 (USD Million)
11.2.2. China Enzyme Replacement Therapy Market Overview, 2017 - 2028 (USD Million)
11.2.2.1. China Enzyme Replacement Therapy Market Overview, By Enzyme Type, 2017 - 2028 (USD Million)
11.2.2.2. China Enzyme Replacement Therapy Market Overview, By Route of Administration, 2017 - 2028 (USD Million)
11.2.2.3. China Enzyme Replacement Therapy Market Overview, By Indication, 2017 - 2028 (USD Million)
11.2.2.4. China Enzyme Replacement Therapy Market Overview, By End User, 2017 - 2028 (USD Million)
11.2.3. Japan Enzyme Replacement Therapy Market Overview, 2017 - 2028 (USD Million)
11.2.3.1. Japan Enzyme Replacement Therapy Market Overview, By Enzyme Type, 2017 - 2028 (USD Million)
11.2.3.2. Japan Enzyme Replacement Therapy Market Overview, By Route of Administration, 2017 - 2028 (USD Million)
11.2.3.3. Japan Enzyme Replacement Therapy Market Overview, By Indication, 2017 - 2028 (USD Million)
11.2.3.4. Japan Enzyme Replacement Therapy Market Overview, By End User, 2017 - 2028 (USD Million)
11.2.4. ASEAN Enzyme Replacement Therapy Market Overview, 2017 - 2028 (USD Million)
11.2.4.1. ASEAN Enzyme Replacement Therapy Market Overview, By Enzyme Type, 2017 - 2028 (USD Million)
11.2.4.2. ASEAN Enzyme Replacement Therapy Market Overview, By Route of Administration, 2017 - 2028 (USD Million)
11.2.4.3. ASEAN Enzyme Replacement Therapy Market Overview, By Indication, 2017 - 2028 (USD Million)
11.2.4.4. ASEAN Enzyme Replacement Therapy Market Overview, By End User, 2017 - 2028 (USD Million)
11.2.5. South Korea Enzyme Replacement Therapy Market Overview, 2017 - 2028 (USD Million)
11.2.5.1. South Korea Enzyme Replacement Therapy Market Overview, By Enzyme Type, 2017 - 2028 (USD Million)
11.2.5.2. South Korea Enzyme Replacement Therapy Market Overview, By Route of Administration, 2017 - 2028 (USD Million)
11.2.5.3. South Korea Enzyme Replacement Therapy Market Overview, By Indication, 2017 - 2028 (USD Million)
11.2.5.4. South Korea Enzyme Replacement Therapy Market Overview, By End User, 2017 - 2028 (USD Million)
11.2.6. Australia Enzyme Replacement Therapy Market Overview, 2017 - 2028 (USD Million)
11.2.6.1. Australia Enzyme Replacement Therapy Market Overview, By Enzyme Type, 2017 - 2028 (USD Million)
11.2.6.2. Australia Enzyme Replacement Therapy Market Overview, By Route of Administration, 2017 - 2028 (USD Million)
11.2.6.3. Australia Enzyme Replacement Therapy Market Overview, By Indication, 2017 - 2028 (USD Million)
11.2.6.4. Australia Enzyme Replacement Therapy Market Overview, By End User, 2017 - 2028 (USD Million)
11.2.7. Rest of Asia Pacific Enzyme Replacement Therapy Market Overview, 2017 - 2028 (USD Million)
11.2.7.1. Rest of Asia Pacific Enzyme Replacement Therapy Market Overview, By Enzyme Type, 2017 - 2028 (USD Million)
11.2.7.2. Rest of Asia Pacific Enzyme Replacement Therapy Market Overview, By Route of Administration, 2017 - 2028 (USD Million)
11.2.7.3. Rest of Asia Pacific Enzyme Replacement Therapy Market Overview, By Indication, 2017 - 2028 (USD Million)
11.2.7.4. Rest of Asia Pacific Enzyme Replacement Therapy Market Overview, By End User, 2017 - 2028 (USD Million)
Chapter 12. South America Enzyme Replacement Therapy Market Overview, By Countries, 2017 - 2028 (USD Million)
12.1. South America Enzyme Replacement Therapy Market Overview, 2017 - 2028 (USD Million)
12.1.1. Market Route of Administration and projections, 2017 - 2028 (USD Million)
12.1.2. South America Enzyme Replacement Therapy Market Overview, By Enzyme Type, 2017 - 2028 (USD Million)
12.1.3. South America Enzyme Replacement Therapy Market Overview, By Route of Administration, 2017 - 2028 (USD Million)
12.1.4. South America Enzyme Replacement Therapy Market Overview, By Indication, 2017 - 2028 (USD Million)
12.1.5. South America Enzyme Replacement Therapy Market Overview, By End User, 2017 - 2028 (USD Million)
12.2. South America Enzyme Replacement Therapy Market Overview, By Countries, 2017 - 2028 (USD Million)
12.2.1. Brazil Enzyme Replacement Therapy Market Overview, 2017 - 2028 (USD Million)
12.2.1.1. Brazil Enzyme Replacement Therapy Market Overview, By Enzyme Type, 2017 - 2028 (USD Million)
12.2.1.2. Brazil Enzyme Replacement Therapy Market Overview, By Route of Administration, 2017 - 2028 (USD Million)
12.2.1.3. Brazil Enzyme Replacement Therapy Market Overview, By Indication, 2017 - 2028 (USD Million)
12.2.1.4. Brazil Enzyme Replacement Therapy Market Overview, By End User, 2017 - 2028 (USD Million)
12.2.2. Argentina Enzyme Replacement Therapy Market Overview, 2017 - 2028 (USD Million)
12.2.2.1. Argentina Enzyme Replacement Therapy Market Overview, By Enzyme Type, 2017 - 2028 (USD Million)
12.2.2.2. Argentina Enzyme Replacement Therapy Market Overview, By Route of Administration, 2017 - 2028 (USD Million)
12.2.2.3. Argentina Enzyme Replacement Therapy Market Overview, By Indication, 2017 - 2028 (USD Million)
12.2.2.4. Argentina Enzyme Replacement Therapy Market Overview, By End User, 2017 - 2028 (USD Million)
12.2.3. Rest of South America Enzyme Replacement Therapy Market Overview, 2017 - 2028 (USD Million)
12.2.3.1. Rest of South America Enzyme Replacement Therapy Market Overview, By Enzyme Type, 2017 - 2028 (USD Million)
12.2.3.2. Rest of South America Enzyme Replacement Therapy Market Overview, By Route of Administration, 2017 - 2028 (USD Million)
12.2.3.3. Rest of South America Enzyme Replacement Therapy Market Overview, By Indication, 2017 - 2028 (USD Million)
12.2.3.4. Rest of South America Enzyme Replacement Therapy Market Overview, By End User, 2017 - 2028 (USD Million)
Chapter 13. Middle East & Africa Enzyme Replacement Therapy Market Overview, By Countries, 2017 - 2028 (USD Million)
13.1. Middle East & Africa Enzyme Replacement Therapy Market Overview, 2017 - 2028 (USD Million)
13.1.1. Market Route of Administration and projections, 2017 - 2028 (USD Million)
13.1.2. Middle East & Africa Enzyme Replacement Therapy Market Overview, By Enzyme Type, 2017 - 2028 (USD Million)
13.1.3. Middle East & Africa Enzyme Replacement Therapy Market Overview, By Route of Administration, 2017 - 2028 (USD Million)
13.1.4. Middle East & Africa Enzyme Replacement Therapy Market Overview, By Indication, 2017 - 2028 (USD Million)
13.1.5. Middle East & Africa Enzyme Replacement Therapy Market Overview, By End User, 2017 - 2028 (USD Million)
13.2. Middle East & Africa Enzyme Replacement Therapy Market Overview, By Countries, 2017 - 2028 (USD Million)
13.2.1. GCC Enzyme Replacement Therapy Market Overview, 2017 - 2028 (USD Million)
13.2.1.1. GCC Enzyme Replacement Therapy Market Overview, By Enzyme Type, 2017 - 2028 (USD Million)
13.2.1.2. GCC Enzyme Replacement Therapy Market Overview, By Route of Administration, 2017 - 2028 (USD Million)
13.2.1.3. GCC Enzyme Replacement Therapy Market Overview, By Indication, 2017 - 2028 (USD Million)
13.2.1.4. GCC Enzyme Replacement Therapy Market Overview, By End User, 2017 - 2028 (USD Million)
13.2.2. South Africa Enzyme Replacement Therapy Market Overview, 2017 - 2028 (USD Million)
13.2.2.1. South Africa Enzyme Replacement Therapy Market Overview, By Enzyme Type, 2017 - 2028 (USD Million)
13.2.2.2. South Africa Enzyme Replacement Therapy Market Overview, By Route of Administration, 2017 - 2028 (USD Million)
13.2.2.3. South Africa Enzyme Replacement Therapy Market Overview, By Indication, 2017 - 2028 (USD Million)
13.2.2.4. South Africa Enzyme Replacement Therapy Market Overview, By End User, 2017 - 2028 (USD Million)
13.2.3. Rest of Middle East & Africa Enzyme Replacement Therapy Market Overview, 2017 - 2028 (USD Million)
13.2.3.1. Rest of Middle East & Africa Enzyme Replacement Therapy Market Overview, By Enzyme Type, 2017 - 2028 (USD Million)
13.2.3.2. Rest of Middle East & Africa Enzyme Replacement Therapy Market Overview, By Route of Administration, 2017 - 2028 (USD Million)
13.2.3.3. Rest of Middle East & Africa Enzyme Replacement Therapy Market Overview, By Indication, 2017 - 2028 (USD Million)
13.2.3.4. Rest of Middle East & Africa Enzyme Replacement Therapy Market Overview, By End User, 2017 - 2028 (USD Million)
Chapter 14. Competitive Landscape
14.1. Competitive Environment, 2021
14.2. Strategic Framework
14.2.1. Partnership/Collaborations/Agreement
14.2.2. Expansion
14.2.3. Mergers & Acquisitions
14.2.4. New Product Development
Chapter 15. Key Vendor Analysis
15.1.Takeda Pharmaceutical Company Limited
15.1.1. Business Overview
15.1.2. Product Benchmarking
15.1.3. Financial Data
15.1.4. Strategic Overview
15.1.5. Key Developments
15.1.6. SWOT Analysis
15.2.Sanofi S.A.
15.2.1. Business Overview
15.2.2. Product Benchmarking
15.2.3. Financial Data
15.2.4. Strategic Overview
15.2.5. Key Developments
15.2.6. SWOT Analysis
15.3.AbbVie Inc.
15.3.1. Business Overview
15.3.2. Product Benchmarking
15.3.3. Financial Data
15.3.4. Strategic Overview
15.3.5. Key Developments
15.3.6. SWOT Analysis
15.4.BioMarin Pharmaceutical Inc.
15.4.1. Business Overview
15.4.2. Product Benchmarking
15.4.3. Financial Data
15.4.4. Strategic Overview
15.4.5. Key Developments
15.4.6. SWOT Analysis
15.5.Amicus Therapeutics
15.5.1. Business Overview
15.5.2. Product Benchmarking
15.5.3. Financial Data
15.5.4. Strategic Overview
15.5.5. Key Developments
15.5.6. SWOT Analysis
15.6.Alexion Pharmaceuticals, Inc. (AstraZeneca)
15.6.1. Business Overview
15.6.2. Product Benchmarking
15.6.3. Financial Data
15.6.4. Strategic Overview
15.6.5. Key Developments
15.6.6. SWOT Analysis
15.7.Janssen Pharmaceuticals (Johnson & Johnson Services, Inc.)
15.7.1. Business Overview
15.7.2. Product Benchmarking
15.7.3. Financial Data
15.7.4. Strategic Overview
15.7.5. Key Developments
15.7.6. SWOT Analysis
15.8.Recordati S.p.A
15.8.1. Business Overview
15.8.2. Product Benchmarking
15.8.3. Financial Data
15.8.4. Strategic Overview
15.8.5. Key Developments
15.8.6. SWOT Analysis
15.9.Pfizer Inc
15.9.1. Business Overview
15.9.2. Product Benchmarking
15.9.3. Financial Data
15.9.4. Strategic Overview
15.9.5. Key Developments
15.9.6. SWOT Analysis
15.10. CHIESI Farmaceutici S.p.A
15.10.1. Business Overview
15.10.2. Product Benchmarking
15.10.3. Financial Data
15.10.4. Strategic Overview
15.10.5. Key Developments
15.10.6. SWOT Analysis
15.11. JCR Pharma
15.11.1. Business Overview
15.11.2. Product Benchmarking
15.11.3. Financial Data
15.11.4. Strategic Overview
15.11.5. Key Developments
15.11.6. SWOT Analysis
Chapter 16. Future Outlook of the Market
Published On:Sep 2022
Base Year:2021
Historical Data:2019-2020
No of Pages:250
Enzyme Replacement Therapy Market Growth, Trends a...
RD Code : HP22